News and Comments

ADVENTRIX (ANX): A REVERSE SPLIT WITH SOME EXCITING NEWS.

  Wednesday, April 28, 2010

Despite the emergence of new biological treatments for cancer, Chemotherapy is still essential, and indispensable as a major treatment for malignancies. The adverse events caused by these chemicals were found to be acceptable as a risk versus the great reward of using chemotherapy. The technological evolution that took place in the past decade and the surfacing of state-of-the-art technologies such as nanotechnology, scientists believed possibilities exist now for improving the adverse effect profiles of these therapeutic molecules. Reformulating the existing products has become an increasingly common product lifecycle-management technique. We read that a 2004 report on the U.S. drug market from BCC, Inc. projected that reformulations would grow from 62% of the market in 2003 to 79% in 2008. Finding ways to modify and improve existing products’ side effect profiles has become feasible after being essential but unreachable goal.  More...


Recent Postings


Archive


Tags

Endometrial Cancer Prolor Biotech (PBTH) NOVOCURE (NVCR) Zerenex Revlimid (lenolidamide) JUNO (JUNO) Agenus (AGEN ADVENTRIX (ANX) Human Longevity (HLI) Vertex (VRTX) SERES THERAPEUTICS (MCRB) Ridaforolimus BIOMARIN (BMRN) Vitae Pharmaceuticals (VTAE) Intermune (ITMN) KERYX (KERX) Sanofi (SNY) Mirati Therapeutics (MRTX) MODERNA TOKAI (TKAOI) Roche (ROCHE) Valeant Pharmaceuticals International (VRX) Adaptimmune (ADAP) Tysabri Micromet (MITI) Alnylam (ALNY) GlaxoSmithKline (GSK) Roche (RHHBY) Idenix (IDIX) JOUNCE THERAPEUTICS (JNCE) Anacor (ANAC) Spike Therapeutics (ONCE) Merck (MRK) Amgen (AMGN) Array Pharmaceuticals (ARRY) galapagos (GLPG) AGOS (ARGS) Elan (ELN) Telaprevir CompuGen (CGEN) Ariad (ARIA) ImmunoGen (IMGN) Intercept (ICPT) Dynavax (DVAX) Biocryst (BCRX) NANTKWEST (NK) Abbott Laboratories (ABT) Auspex (ASPX) Illumina (ILMN) RenenxBio (RGNX) Theravance (THRX) Sanofi (SNA) Herceptin VANDA (VNDA) Global Cell Therapeutics (GBT) CEMPRA (CEMP) HALOZYME (HALO) NEKTAR (NKTR)) Anadys (ANDS) Aimmune Therapeutics (AIMT) Dendreon (DNDN) Bristol-Myers Squibb (BMY) Incyte (INCY) Multiple Myeloma Agenus (AGEN) Prosensa (RNA) Jazz Pharmaceuticals (JAZZ) Exelixis (EXEL) Inovio (INO) ARCA (ABIO) REGULUS (RGLS) C4 Therapeutics PTC Therapeutics (PTCT) Advaxis (ADXS) Regeneron (REGN) Ionis (IONS) Sanofi-Aventis (SAN) KITE (KITE) PORTOLA (PTLA) ABBVIE (ABBV) Intrexon (XON) SUNESIS PHARMACEUTICALS (SNSS) OSI (OSIP) Onyx (ONXX) INNOVIVA (INVA) Seattle Genetics (SGEN) Trastuzumab-DM1 CRISPR Therapeutics (CRSP) ZALTRAP™ Alder Biopharmaceuticals (ALDR) Sangamo (SGMO) Biogen Idec (BIIB) Benlysta (belimumab) ACADIA (ACAD) Velcade (bortezomib) GUARDIAN HEALTH Gilead (GILD) Galena (GALE) SYNTA (SNTA) Cytokinetics (CYTK) Sarepta (SRPT) Genentech ISIS (ISIS) Editas (EDIT) IDERA (IDRA) ARGOS (ARGS) AstraZeneca (AZN) Bellicum (BLCM) Human Genome Sciences (HGSI) Ocular Therapeutix (OCUL) AERIE PHARMACEUTICALS Xoma (XOMA) Rapamune Ziofpharm (ZIOP) Pluristem (PSTI) Theravance Bio Pharma (TBPH) Sequenom (SQNM)